Search

Author/Creator Reynolds, Craig H.

1. Clinicopathologic Features of Advanced Squamous NSCLC. Issue 9 (September 2016)

Authors:
Socinski, Mark A.; Obasaju, Coleman; Gandara, David; Hirsch, Fred R.; Bonomi, Philip; Bunn, Paul; Kim, Edward S.; Langer, Corey J.; Natale, Ronald B.; Novello, Silvia; Paz‐Ares, Luis; Pérol, Maurice; Reck, Martin; Ramalingam, Suresh S.; Reynolds, Craig H.; Spigel, David R.; Stinchcombe, Thomas E....
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 9(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment. Issue 12 (December 2016)

Authors:
Langer, Corey J.; Obasaju, Coleman; Bunn, Paul; Bonomi, Philip; Gandara, David; Hirsch, Fred R.; Kim, Edward S.; Natale, Ronald B.; Novello, Silvia; Paz‐Ares, Luis; Pérol, Maurice; Reck, Martin; Ramalingam, Suresh S.; Reynolds, Craig H.; Socinski, Mark A.; Spigel, David R.; Wakelee, Heather; Mayo...
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 12(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer. Issue 2 (February 2015)

Authors:
Spigel, David R.; Patel, Jyoti D.; Reynolds, Craig H.; Garon, Edward B.; Hermann, Robert C.; Govindan, Ramaswamy; Olsen, Mark R.; Winfree, Katherine B.; Chen, Jian; Liu, Jingyi; Guba, Susan C.; Socinski, Mark A.; Bonomi, Philip
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 2(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer. Issue 2 (February 2015)

Authors:
Spigel, David R.; Patel, Jyoti D.; Reynolds, Craig H.; Garon, Edward B.; Hermann, Robert C.; Govindan, Ramaswamy; Olsen, Mark R.; Winfree, Katherine B.; Chen, Jian; Liu, Jingyi; Guba, Susan C.; Socinski, Mark A.; Bonomi, Philip
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 2(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search